-+-+-+- NEXT SEGMENT -+-+-+- Segment of length 9226 From redacted@cybernothing.org Thu Jul 01 08:00:36 2004 Return-Path: <redacted@peru.com> Received: from localhost by nelson with LMTP; Thu, 01 Jul 2004 01:06:39 -0400 Received: from ralph.harvard.edu (ralph.harvard.edu [128.103.149.85]) by nelson.harvard.edu (Switch-3.1.3/Switch-3.1.0) with SMTP id i6156do7005282; Thu, 1 Jul 2004 01:06:39 -0400 (EDT) Received: from camail.harvard.edu ([127.0.0.1]) by ralph.harvard.edu (SAVSMTP 3.1.6.45) with SMTP id M2004070101063805327 ; Thu, 01 Jul 2004 01:06:38 -0400 Received: from ralph (localhost [127.0.0.1]) by camail.harvard.edu (Postfix) with SMTP; Thu, 1 Jul 2004 01:06:39 -0400 (EDT) Received: from lenny.harvard.edu (lenny.harvard.edu [128.103.56.198]) by camail.harvard.edu (Postfix) with ESMTP id 586935E; Thu, 1 Jul 2004 01:06:35 -0400 (EDT) Received: from 128.103.56.198 (unknown [211.228.78.171]) by lenny.harvard.edu (Postfix) with SMTP id B71101766; Thu, 1 Jul 2004 01:06:32 -0400 (EDT) X-Message-Info: p36VRH1fs6E76JJDBOlhW9ndbU1dtoHQfXY15PHM7 Received: (from redacted@211.228.78.171) by oust8.24.156.208.48 (7.55.8/9.97.3) id z07LXbV39170; Thu, 01 Jul 2004 04:11:19 +0100 Message-ID: <redacted@dkdsmk@peru.com> Reply-To: "Lucille " <redacted@peru.com> From: "Lucille " <redacted@peru.com> To: "Zittrain" <redacted@law.harvard.edu> Subject: [POSSIBLE SPAM] KWBT is About To Make a Move Date: Thu, 01 Jul 2004 06:07:19 +0300 MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="--33372848591082034" X-Spam-Flag: YES X-Spam-Checker-Version: SpamAssassin 2.63-soc_rev_22 (2004-01-11) on ralph X-Spam-Level: **************** X-Spam-Status: Yes, hits=16.1 required=4.0 autolearn=no version=2.63-soc_rev_22 OUR LAST PICK ************************************************************************* Congratulations to all investors who took advantage of our last Stock Pick!!! GRYW - The stock was initially profiled at .40 cents and reached $1.80 in two weeks. The situation with our new stock pick is similar so act now to get in on the move! ************************************************************************* ++ Major Trading Alert : Late breaking news...++ ******Investors have not yet had the opportunity to trade on this information.****** After the close of trading on Friday, Kiwa biotech announced... Three Orders in Q2 Represent an aggregate 700% Increase from Distributors Previous Orders in Dollar Terms LOS ANGELES, June 25, 2004 (PRIMEZONE) -- Kiwa Bio-Tech Products Group Corporation (``the Company'' or ``KIWA'') (OTC BB:KWBT) announced today that a China-based distributor of its products has placed its third order this quarter, which represents a significant increase over the previous order by this repeat customer. Entering Q2, the distributor placed three orders which total 7 times the size of the order placed by this customer in Q1. ******Investors have not yet had the opportunity to trade on this information.****** The hottest stock Today - Watch KWBT We expect some strong demand for this stock in the near future!!!!! The Stock is EXTREMELY TIGHT - The float is only 4M shares!!! Get on Board now and enjoy some great profits with KWBT CURRENT PRICE - $.32 SPECULATIVE NEAR TERM TARGET PRICE - $.80 SPECULATIVE LONG TERM TARGET PRICE - $1.85 KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT * KWBT About the Company: ------------------------------------------------------------------------ Based in the City of Industry, California, with manufacturing centers in mainland China, KIWA Bio-Tech Products Group Corporation is a public company (OTCBB: KWBT) that develops, manufactures and distributes innovative, cost-effective, and environmentally-safe biotechnology products to agricultural markets. The company is a pioneer in commercialization of biotechnology, having a manufacturing base in Shandong Province, China and plans to distribute bio-tech products worldwide. With 20 years of research and development experience in biotechnology, KIWA's patented products are produced through a cost-effective manufacturing process. KIWA's first marketplace entry is Mainland China, with an American presence planned by 2005. With approval and subsidies from the Chinese government, KIWA has established a manufacturing center which is a well developed distribution point for the world's most populated country. The Market: ------------------------------------------------------------------------- KIWA Bio-Tech recognized early the dire need in mainland China for affordable, easy-to-use organic agricultural products, as well as the difficulties in distributing their products to farmers in the world's most populous country. With over 1.3 billion people, China possesses 7% of the world's agricultural land but supports 20% of the world's population. With these demands the strain on arable land in China is enormous. Overuse of chemical herbicides and insecticides hold the potential to destroy the limited water supply of China, making organic compounds an obvious alternative. With China's underdeveloped farm communities, KIWA strives to provide the average local farmer with the ability to grow higher quality produce and greater crop yields. Agribusiness is 14% of China's Gross Domestic Product, totaling as much as $180 billion in 2002 alone. With this type of market potential, China was an obvious first choice for KIWA's full-scale entry into the "Agri-Bio" marketplace. In the coming year an entrance into the American agricultural market is planned, but KIWA will establish the immense value of their product in Chinese agribusiness first. ------------------------------------------------------- We wish you profitable trading!! --------------- Disclaimer --------------- Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will," "part of: "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. Please have in mind that the inter retation of the writer of this newsletter about the news published by the company does not represent the company official statement and in fact may differ from the real meaning of what the news release meant to say. Please read the news release by yourself and judge by yourself about the details in it. In compliance with Section 17(b), we disclose the holding of KWBT shares prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. Since we own shares, there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward-looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties, that could cause results to differ materially from those set forth in the forward- looking statements. Please be advised that nothing within this email shall constitute a solicitation or an offer to buy or sell any security mentioned herein. This newsletter is neither a registered investment advisor nor affiliated with any broker or dealer. All statements made are our express opinion only and should be treated as such. We may own, buy and sell any securities mentioned at any time. This report includes forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements may include terms as "expect", "believe", "may", "will", "move", "undervalued" and "intend" or similar terms. This newsletter was paid $3,500 from third party to send this report. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You may lose money from investing in Penny Stocks. -+-+-+- NEXT SEGMENT -+-+-+- Segment of length 9226 From redacted@cybernothing.org Thu Jul 01 08:00:36 2004 Return-Path: <redacted@peru.com> Received: from localhost by nelson with LMTP; Thu, 01 Jul 2004 01:06:39 -0400 Received: from ralph.harvard.edu (ralph.harvard.edu [128.103.149.85]) by nelson.harvard.edu (Switch-3.1.3/Switch-3.1.0) with SMTP id i6156do7005282; Thu, 1 Jul 2004 01:06:39 -0400 (EDT) Received: from camail.harvard.edu ([127.0.0.1]) by ralph.harvard.edu (SAVSMTP 3.1.6.45) with SMTP id M2004070101063805327 ; Thu, 01 Jul 2004 01:06:38 -0400 Received: from ralph (localhost [127.0.0.1]) by camail.harvard.edu (Postfix) with SMTP; Thu, 1 Jul 2004 01:06:39 -0400 (EDT) Received: from lenny.harvard.edu (lenny.harvard.edu [128.103.56.198]) by camail.harvard.edu (Postfix) with ESMTP id 586935E; Thu, 1 Jul 2004 01:06:35 -0400 (EDT) Received: from 128.103.56.198 (unknown [211.228.78.171]) by lenny.harvard.edu (Postfix) with SMTP id B71101766; Thu, 1 Jul 2004 01:06:32 -0400 (EDT) X-Message-Info: p36VRH1fs6E76JJDBOlhW9ndbU1dtoHQfXY15PHM7 Received: (from redacted@211.228.78.171) by oust8.24.156.208.48 (7.55.8/9.97.3) id z07LXbV39170; Thu, 01 Jul 2004 04:11:19 +0100 Message-ID: <redacted@dkdsmk@peru.com> Reply-To: "Lucille " <redacted@peru.com> From: "Lucille " <redacted@peru.com> To: "Zittrain" <redacted@law.harvard.edu> Subject: [POSSIBLE SPAM] KWBT is About To Make a Move Date: Thu, 01 Jul 2004 06:07:19 +0300 MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="--33372848591082034" X-Spam-Flag: YES X-Spam-Checker-Version: SpamAssassin 2.63-soc_rev_22 (2004-01-11) on ralph X-Spam-Level: **************** X-Spam-Status: Yes, hits=16.1 required=4.0 autolearn=no version=2.63-soc_rev_22 OUR LAST PICK ************************************************************************* Congratulations to all investors who took advantage of our last Stock Pick!!! GRYW - The stock was initially profiled at .40 cents and reached $1.80 in two weeks. The situation with our new stock pick is similar so act now to get in on the move! ************************************************************************* ++ Major Trading Alert : Late breaking news...++ ******Investors have not yet had the opportunity to trade on this information.****** After the close of trading on Friday, Kiwa biotech announced... Three Orders in Q2 Represent an aggregate 700% Increase from Distributors Previous Orders in Dollar Terms LOS ANGELES, June 25, 2004 (PRIMEZONE) -- Kiwa Bio-Tech Products Group Corporation (``the Company'' or ``KIWA'') (OTC BB:KWBT) announced today that a China-based distributor of its products has placed its third order this quarter, which represents a significant increase over the previous order by this repeat customer. Entering Q2, the distributor placed three orders which total 7 times the size of the order placed by this customer in Q1. ******Investors have not yet had the opportunity to trade on this information.****** The hottest stock Today - Watch KWBT We expect some strong demand for this stock in the near future!!!!! The Stock is EXTREMELY TIGHT - The float is only 4M shares!!! Get on Board now and enjoy some great profits with KWBT CURRENT PRICE - $.32 SPECULATIVE NEAR TERM TARGET PRICE - $.80 SPECULATIVE LONG TERM TARGET PRICE - $1.85 KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT* KWBT * KWBT About the Company: ------------------------------------------------------------------------ Based in the City of Industry, California, with manufacturing centers in mainland China, KIWA Bio-Tech Products Group Corporation is a public company (OTCBB: KWBT) that develops, manufactures and distributes innovative, cost-effective, and environmentally-safe biotechnology products to agricultural markets. The company is a pioneer in commercialization of biotechnology, having a manufacturing base in Shandong Province, China and plans to distribute bio-tech products worldwide. With 20 years of research and development experience in biotechnology, KIWA's patented products are produced through a cost-effective manufacturing process. KIWA's first marketplace entry is Mainland China, with an American presence planned by 2005. With approval and subsidies from the Chinese government, KIWA has established a manufacturing center which is a well developed distribution point for the world's most populated country. The Market: ------------------------------------------------------------------------- KIWA Bio-Tech recognized early the dire need in mainland China for affordable, easy-to-use organic agricultural products, as well as the difficulties in distributing their products to farmers in the world's most populous country. With over 1.3 billion people, China possesses 7% of the world's agricultural land but supports 20% of the world's population. With these demands the strain on arable land in China is enormous. Overuse of chemical herbicides and insecticides hold the potential to destroy the limited water supply of China, making organic compounds an obvious alternative. With China's underdeveloped farm communities, KIWA strives to provide the average local farmer with the ability to grow higher quality produce and greater crop yields. Agribusiness is 14% of China's Gross Domestic Product, totaling as much as $180 billion in 2002 alone. With this type of market potential, China was an obvious first choice for KIWA's full-scale entry into the "Agri-Bio" marketplace. In the coming year an entrance into the American agricultural market is planned, but KIWA will establish the immense value of their product in Chinese agribusiness first. ------------------------------------------------------- We wish you profitable trading!! --------------- Disclaimer --------------- Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will," "part of: "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. Please have in mind that the inter retation of the writer of this newsletter about the news published by the company does not represent the company official statement and in fact may differ from the real meaning of what the news release meant to say. Please read the news release by yourself and judge by yourself about the details in it. In compliance with Section 17(b), we disclose the holding of KWBT shares prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. Since we own shares, there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward-looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties, that could cause results to differ materially from those set forth in the forward- looking statements. Please be advised that nothing within this email shall constitute a solicitation or an offer to buy or sell any security mentioned herein. This newsletter is neither a registered investment advisor nor affiliated with any broker or dealer. All statements made are our express opinion only and should be treated as such. We may own, buy and sell any securities mentioned at any time. This report includes forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements may include terms as "expect", "believe", "may", "will", "move", "undervalued" and "intend" or similar terms. This newsletter was paid $3,500 from third party to send this report. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED COMPANY. You may lose money from investing in Penny Stocks.